Carbapenemase Producing Enterobacteriaceae (CPE) are increasing worldwide [1, 2] and pose a significant threat to public health. The burden of CPE infection is multifaceted, encompassing adjustment of treatment regimens [3, 4], increased duration of inpatient stay [5], associated morbidity [6] and mortality [5, 7, 8] , in addition to the wider burden it poses on healthcare systems, with financial and societal implications [9] . The rapid spread of CPE within endemic areas [10] and in the health care setting [11] is well documented. Furthermore, illustrates the capacity of CPE exposure to lead to gut colonisation [12] .
Methods

In vitro gut model
The gut model utilised in this study is based on that of MacFarlane et al, and has been validated against physico-chemical and microbiological properties of the colonic contents of sudden death victims [17] . It is a triple-stage continuous culture system, arranged in a weir cascade formation, that simulates the proximal, medial and distal sections of the human colon. The three vessels are maintained at 37°C (via circulating waterbath), at physiologically relevant pH and volume (Vessel 1 -280mL, pH 5.5±0.2; Vessel 2 -300mL, pH 6.2±0.2; Vessel 3 -300mL, pH 6.8±0.2).
The system is continuously sparged with nitrogen to maintain anaerobicity, and top fed with a complex growth media [19] at a controlled rate (D=0.015 h-1; system retention time 66.7h). The gut model is inoculated with pooled faecal slurry (10% w/v).
Collection of human faecal material
Human faeces used to create the faecal emulsion was collected from healthy volunteers (N= 4, aged 18-75), without preceding antibiotic therapy (past three months). Faecal samples were transported in sealed anaerobic bags and placed in an anaerobic cabinet within 12 h of production. All samples were negative for the presence of CPE upon screening [(Biomerieux chrom ID® CARBA-SMART (carbasmart) & Cepheid Xpert® Carba-R assay (XCR)] and were pooled to produce ≈ 50 g of faeces. The subsequent pooled faecal material was emulsified with 500 mL of prereduced PBS and filtered through sterile muslin to create a smooth 10% w/v faecal slurry.
CPE strains
Three clinical isolates of carbapenemase producing K. pneumoniae with distinct carbapenemase genes were used in this study. The carbapenemase genes selected were blaKPC (KPC) gene encoded on the PKpQiL-D2 plasmid, minimum inhibitory 
Experimental design
Three gut models were run in parallel for a total 38 days. The models were initially primed with pooled CPE negative faeces (from four healthy volunteers) and left for two weeks to allow the bacterial populations to equilibrate. Each model was exposed to increasing daily inocula of a different carbapenemase producing K. pneumonia strain (described above) from a 10-fold dilution series of a fresh overnight culture in nutrient broth (range 1.9-8.9 log10 cfu over 8 days) ( Figure 1 ). Figure 1 : Schematic diagram illustrating the experimental timeframes and sampling points for this study. Period A represents the two week equilibration period following priming with faecal slurry. Period B involved the inoculation of CPE strains which began on day 15. Period C represents the post inoculation sampling period. The solid black dots represent sampling points.
All three models ran as per Figure 1 , with twice daily CPE screening of bacterial populations between days 15 and 25. CPE screening was then reduced to daily and subsequently twice weekly in further phases of the experiment
Inoculation of Gut models with CPE isolates
Each model was inoculated with 1 m/L of an overnight culture (5 mL nutrient broth) of a different CPE strain (described previously) ( Figure 1 ). Each strain was diluted in a 10-fold series to 10 -7 in peptone water. The lowest (10 -7 ) dilution was added to the model on the first day of inoculation (day 15). This was increased 10-fold daily until a neat solution was added on day 22 of the experiment. Cultures were enumerated on MacConkey agar to ensure comparable overnight cultures. This confirmed inoculum levels were as expected (Appendix 1).
Population sampling
Indigenous gut microbiota populations were identified and enumerated daily using a variety of selective and non-selective agars, as previously described [20] . CPE populations were identified using five different detection tests which encompassed 
Data handling and analysis
Comparative analysis of all screening methods was undertaken using both single and strict criteria as described below:
Single criterion: 1. Any growth of Enterobacteriaceae on agar plates was considered positive (log10 cfu/mL reported); 2. For molecular assays, all reported Ct values were interpreted as positive up to ≤40 cycles for XCR or ≤50 cycles for CD CPE. A single positive result for any of the triplicate samples was recorded as positive ( Table 2) .
Strict criteria of 1. Triplicate positive culture for selective media; 2. XCR: Using the internal algorithm reporting the sample as positive and samples were considered negative unless all three replicates were positive by the assay algorithm; 3 CD CPE:
As there is no diagnostic algorithm associated with this assay, a clinical cut-off for a negative result of a Ct value ≥35 was applied, as is often applied to routine diagnostic in-house PCR assays [21, 22] (Table 2) . Again, samples were considered negative unless all three replicates were positive using this cut-off.
Results
A total of 237 samples were tested using the five screening methods. No CPE strains were identified during the equilibrium phase ( Figure 1 .Period A) by either culture or molecular technique. For all assays, detection levels (as measured by log10 cfu/mL or 1/Ct) increased as the concentration of the inocula increased ( Figure   2 ). Selective media detected CPE earlier or at the same time as molecular methods with the exception of MAC IMI, which showed poor performance overall; MAC IMI was subsequently discontinued in the KPC model ( Figure 1 ).
Detection of CPE within the gut model
CPE were detectable only after an inoculation of ~4.9 log10 cfu/mL (Figure 1 Table 2 ). Populations increased with higher inocula, peaking at 5-6 log10 cfu/mL in vessel 3 for all gut models irrespective of CPE strain (Figure 1-3 ).
Interestingly, CPE populations remained stable within the gut microbiota on cessation of CPE inoculation for all models. Following the final inoculum of ~8.9 log10 cfu/mL, carbapenem producing (CP) K. pneumoniae populations stabilised at 3-5 log10 cfu/mL for the remainder of the experiment, with no evidence of 'washing out' of CPE populations in any of the three models.
Ct values stabilised in all models (Figure 1-3) , and have been reported as 1/Ct to allow graphical presentation with viable counts. Correlation of Ct Values and viable counts showed that at higher culture density there were corresponding lower Ct values. For both XCR and CD CPE, a Ct valve of ≤35 corresponded to triplicate positive culture and hence was predictive of colonisation. Performance of screening methods was reported in days from the onset of the experiment when the assay became positive (as per data handing and analysis described above) ( 
Relative sensitivity of CPE screening methods
The MAC-IMI agar displayed a lower limit of detection (LOD) of 1.66 log10 cfu/ml. Both commercial chromogenic agars had similar sensitivity and a lower LOD of 0.82 log10 cfu/mL. The relative sensitivity and specificity of the molecular methods were calculated compared to the reference method, which was triplicate positive culture (Carba-Smart) and summarised in 
Detection of strains not inoculated into the models
Any detection of a CPE gene that has not been directly inoculated into the model was considered a false positive result ( investigated. Carba-Smart has been previously shown to be superior to other selective media [25] when tested using rectal swabs.
We found the ESBL agar was less sensitive than the Carba-Smart; however, it did detect the presence of CPE sooner than the molecular platforms (XCR, CD CPE). The CD CPE showed a higher sensitivity for CPE detection but also produced a higher rate of discrepant results, 15% (n=37/237) versus 0.4% (n=1/237), when compared with XCR. These possible false positive results were primarily centred on OXA 48 and NDM resistance genes. It is possible that these false positives were true positives, although this is unlikely as the results were sporadic and not reproducible.
The CD CPE assay is a multistep open chamber system and therefore contamination could potentially account for the false positive rate; however, our false positive rate of 15% corroborates previous studies [22, 28, 29] . This high false positive rate undermines the use of this assay for infection control practices.
Conclusion
The in-vitro human gut model is a novel way to evaluate CPE screening performance, notably allowing direct comparison of a variety of screening platforms for a range of test organisms in a controlled environment. Using a simulated human colonic environment, we have shown that CPE exposure can lead to insertion, multiplication and persistence of CPE strains within the human microbiota, providing evidence of new colonisation events. We have shown insight into the performance of five CPE recovery methods, and identified Carba-Smart as the most sensitive method.
Chromogenic agars provide convenient and inexpensive CPE screening tools, albeit yielding slower results without enzymatic information. 
